Thromboinflammation in dogs with virulent babesiosis. [PDF]
Goddard A +4 more
europepmc +1 more source
In vitro quality assessment of red blood cells and plasma units in DEHT/SAGM bags and DEHT/PAGGSM bags during storage. [PDF]
Lotens A +8 more
europepmc +1 more source
The effects of recombinant human activated factor VII and tranexamic acid on traumatic bleeding and mortality in mice. [PDF]
Chumappumkal Joseph B +7 more
europepmc +1 more source
Beyond Rebalanced Haemostasis: Haemostatic Phenotypes, Thrombin Generation, and Clinical Risk in Chronic Liver Disease. [PDF]
Agouba SM +9 more
europepmc +1 more source
Systemic Host Proteomic Signatures as Dynamic Markers for Monitoring Pulmonary Tuberculosis Treatment Response. [PDF]
Alfarafisa NM +7 more
europepmc +1 more source
Biomarkers for diagnosis, disease progression, and therapeutic response in psoriasis vulgaris: A mini-review. [PDF]
Edwar SQ +4 more
europepmc +1 more source
Increased N-Terminal Cleavage of Alpha-2-Antiplasmin in Patients With Liver Cirrhosis [PDF]
The activity of alpha-2-antiplasmin (α2AP), the main fibrinolytic inhibitor, is modified by N- and C-terminal proteolytic cleavages. C-terminal cleavage converts plasminogen-binding α2AP (PB-α2AP) into a non-plasminogen-binding derivative. N-terminal cleavage by antiplasmin-cleaving enzyme (APCE), a soluble, circulating derivative of fibroblast ...
Frank Leebeek, H L A Janssen, D C Rijken
exaly +4 more sources
Inhibition of Clot-Bound Alpha 2-Antiplasmin Enhances in Vivo Thrombolysis.
Recent experiments in vitro have shown that inhibition of human alpha 2-antiplasmin by a monoclonal antibody (MAb RWR) markedly enhances clot lysis by plasminogen activators. To extend these studies in vivo, we tested whether inhibition of clot or fibrin-
G L Reed, G R Matsueda, E Häber
exaly +2 more sources
A Bleeding Disorder Due to Deficiency of Alpha 2-Antiplasmin [PDF]
A deficiency of alpha 2-antiplasmin has been identified in a female patient with severe and frequent bleeding episodes. Routine coagulation and platelet assays of the patient's plasma were within normal limits. However, abnormally rapid whole blood or dilute plasma clot lysis times and an abnormal FXIII test in which clots were lysed in the presence of
Ef Plow
exaly +4 more sources

